197 related articles for article (PubMed ID: 33717149)
1. An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.
Carnero Contentti E; Delgado-García G; Criniti J; López PA; Pettinicchi JP; Cristiano E; Miguez J; Correa-Díaz EP; Álvarez Pucha MO; Miño Zambrano JE; Gómez-Figueroa E; Rivas-Alonso V; Flores-Rivera J; Tkachuk V; Caride A; Rojas JI
Front Immunol; 2021; 12():628024. PubMed ID: 33717149
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study.
Villa AM; Manin A; Seimandi C; Finkelsteyn AM; Ramos G; Tenembaum S
Mult Scler Relat Disord; 2023 Nov; 79():105018. PubMed ID: 37806234
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD.
Wang L; Xia R; Li X; Shan J; Wang S
Front Immunol; 2023; 14():1293100. PubMed ID: 38259484
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?
Chu F; Shi M; Liu C; Zhu J
Clin Exp Immunol; 2023 Oct; 213(3):363-370. PubMed ID: 37161978
[TBL] [Abstract][Full Text] [Related]
5. Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome.
Doubrovinskaja S; Korporal-Kuhnke M; Jarius S; Haas J; Wildemann B
J Neurol; 2024 May; 271(5):2866-2870. PubMed ID: 37962590
[TBL] [Abstract][Full Text] [Related]
6. The Neutrophil-to-Lymphocyte Ratio and the Monocyte-to-Lymphocyte Ratio Predict Expanded Disability Status Scale Score at One Year in Pediatric Neuromyelitis Optica Spectrum Disorder but not in Multiple Sclerosis.
Devlin L; Gombolay G
Pediatr Neurol; 2023 Jun; 143():84-88. PubMed ID: 37044044
[TBL] [Abstract][Full Text] [Related]
7. Different clinical phenotypes of AQP4-IgG positive NMOSD in two first degree relatives.
Ssemmanda S; Musubire AK
BMC Neurol; 2023 Sep; 23(1):315. PubMed ID: 37667215
[TBL] [Abstract][Full Text] [Related]
8. Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ.
Nakajima A; Yanagimura F; Saji E; Shimizu H; Toyoshima Y; Yanagawa K; Arakawa M; Hokari M; Yokoseki A; Wakasugi T; Okamoto K; Takebayashi H; Fujii C; Itoh K; Takei YI; Ohara S; Yamada M; Takahashi H; Nishizawa M; Igarashi H; Kakita A; Onodera O; Kawachi I
Acta Neuropathol; 2024 Apr; 147(1):76. PubMed ID: 38658413
[TBL] [Abstract][Full Text] [Related]
9. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel T; Giglhuber K; Aktas O; Ayzenberg I; Bellmann-Strobl J; Häußler V; Havla J; Hellwig K; Hümmert MW; Jarius S; Kleiter I; Klotz L; Krumbholz M; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Trebst C; Tumani H; Warnke C; Wildemann B; Berthele A;
J Neurol; 2024 Jan; 271(1):141-176. PubMed ID: 37676297
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia.
Sechi E; Puci M; Pateri MI; Zara P; Othmani S; Sotgiu S; Saddi MV; Leoni S; Fenu G; Melis M; Sotgiu G; Solla P; Cocco E; Frau J
Mult Scler Relat Disord; 2024 May; 85():105522. PubMed ID: 38461730
[TBL] [Abstract][Full Text] [Related]
11. Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder.
Fu Y; Bi J; Yan Y; Sun X; Li K; Kim SY; Han SM; Zhou L; Li R; Huang Q; Wang N; Lin A; Kim HJ; Qiu W
JAMA Neurol; 2023 Oct; 80(10):1105-1112. PubMed ID: 37669037
[TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction in AQP4 NMOSD and MS; a potential predictor of relapse and prognosis.
Chen Y; Wang Y; Jin R; Lv Z; Fu Y; Teng J; Wang X
Clin Immunol; 2024 Feb; 259():109875. PubMed ID: 38141747
[TBL] [Abstract][Full Text] [Related]
13. Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review.
Siriratnam P; Huda S; Butzkueven H; van der Walt A; Jokubaitis V; Monif M
Autoimmun Rev; 2024 Feb; 23(2):103499. PubMed ID: 38061621
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic spinal lesions in patients with AQP4-IgG-positive NMOSD: A real-world cohort study.
Cao S; Zhu Y; Wu X; Du J; Xu S; Cui P; Li Q; Xia M; Xue Q; Tian Y
Ann Clin Transl Neurol; 2024 Apr; 11(4):905-915. PubMed ID: 38311755
[TBL] [Abstract][Full Text] [Related]
15. Role of C5 inhibitors in neuromyelitis optica spectrum disorders with seropositive anti-aquaporin-4 antibody: A systematic review and meta-analysis.
Makkawi S; Salamatullah HK; Alkhiri A; Faidah DE; Afif LM; Bukhari JI; Abulaban A; Al Malik Y; Levy M
Mult Scler Relat Disord; 2024 May; 85():105524. PubMed ID: 38479045
[TBL] [Abstract][Full Text] [Related]
16. Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
Masuda H; Mori M; Hirano S; Uzawa A; Uchida T; Muto M; Ohtani R; Aoki R; Hirano Y; ; Kuwabara S
Sci Rep; 2023 Aug; 13(1):12631. PubMed ID: 37537208
[TBL] [Abstract][Full Text] [Related]
17. Deciphering prognostic indicators in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder: An integrative review of demographic and laboratory factors.
Guo RY; Wang WY; Huang JY; Jia Z; Sun YF; Li B
Mult Scler; 2024 Jan; 30(1):7-15. PubMed ID: 37982449
[TBL] [Abstract][Full Text] [Related]
18. Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment.
Sen S; Tuncer A; Terzi M; Bunul SD; Ozen-Acar P; Altunrende B; Ozakbas S; Tutuncu M; Uygunoglu U; Akman-Demir G; Karabudak R; Efendi H; Siva A
Mult Scler Relat Disord; 2023 Nov; 79():104949. PubMed ID: 37678131
[TBL] [Abstract][Full Text] [Related]
19. Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort.
Tkachuk V; Balbuena Aguirre ME; Alonso R; Barboza A; Liwacki SDV; Mainella C; Rojas JI; Silva BA; Tavolini D; Zanga G; López P; Delgado Garcia G; Carnero Contentti E
Mult Scler Relat Disord; 2023 Feb; 70():104485. PubMed ID: 36610362
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio correlates with disease activity in myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) in children.
Benetou C; Berti F; Hemingway C; Hacohen Y; Lim M
Mult Scler Relat Disord; 2020 Oct; 45():102345. PubMed ID: 32653734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
